Loading…
Chambers' Apothecary was cited for marketing Blood Pressure Support and CoEnzyme Q10 products as unapproved drugs through disease claims on their website, including statements that the products could "help control high blood pressure," "lower cholesterol," and "improve health of blood vessels." These claims violated the Federal Food, Drug, and Cosmetic Act by establishing the products as drugs intended for the cure, mitigation, treatment, or prevention of disease without FDA approval. The company was selling these products as dietary supplements while making therapeutic claims that classified them as new drugs under section 201(g)(1)(B) of the Act.